Therefore, modulation of IL-7 by proteases secreted by infiltrating leukocytes or cancer cells are a plausible process both in MS and in cancer pathologies and these elements justify further investigation of the functional implications of IL-7 proteolytic processing. Here, IL7 is linked to myeloid sarcoma.